Nick B. Tressler - 01 Dec 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Financial Officer
Signature
/s/ Nick B. Tressler
Issuer symbol
VTGN
Transactions as of
01 Dec 2025
Net transactions value
$0
Form type
4
Filing time
04 Dec 2025, 06:07:03 UTC
Previous filing
31 May 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tressler Nick B. Chief Financial Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Nick B. Tressler 03 Dec 2025 0001794362

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Common Stock (Right to Buy) Award +150,000 150,000 01 Dec 2025 Common Stock 150,000 $4.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
F2 The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer.